Patient-Centered Goal-Setting in the National Diabetes Prevention Program: A Pilot Study
- PMID: 34404739
- PMCID: PMC8546276
- DOI: 10.2337/dc21-0677
Patient-Centered Goal-Setting in the National Diabetes Prevention Program: A Pilot Study
Abstract
Objective: Difficulty achieving preset goals (e.g., ≥5% weight loss, ≥150 min of weekly physical activity) in the yearlong National Diabetes Prevention Program (NDPP) can prompt dropout and diminish benefits. We piloted a more patient-centered NDPP adaptation (NDPP-Flex) that promotes a variety of attainable and individually tailored goals to reduce diabetes risks, along with flexibility to adjust goals each week as needed.
Research design and methods: Retention, physical activity, weight, and glycated hemoglobin (HbA1c) were evaluated among diverse participants with diabetes risks who received our pilot of NDPP-Flex beginning in January and July 2018 (n = 95), with a planned comparison with standard NDPP delivery in preceding cohorts that launched between September 2016 and October 2017 (n = 245). Both the standard NDPP and NDPP-Flex interventions were 1 year in duration and implemented in phases (i.e., nonrandomized).
Results: Average adjusted retention (e.g., 158.90 ± 15.20 vs. 166.71 ± 9.38 days; P = 0.674), physical activity (157.97 ± 11.91 vs. 175.64 ± 7.54 weekly min; P = 0.231), and weight loss (1.46 ± 0.38% vs. 1.90 ± 0.24%; P = 0.396) were similar between NDPP-Flex versus standard NDPP. However, NDPP-Flex participants had greater HbA1c reduction on average (0.22 ± 0.05% vs. 0.06 ± 0.03%; P = 0.018) and were more likely to have normoglycemia at follow-up (odds ratio 4.62; P = 0.013 [95% CI 1.38-15.50]) than participants in the standard NDPP.
Conclusions: An adapted, more patient-centered NDPP that focuses on flexible, self-selected goals may be a promising strategy to improve glycemia even in the absence of substantial weight loss.
© 2021 by the American Diabetes Association.
Figures
Comment in
-
Rethinking the Goals of Diabetes Prevention Programs.Diabetes Care. 2021 Nov;44(11):2457-2459. doi: 10.2337/dci21-0038. Diabetes Care. 2021. PMID: 34670795 Free PMC article. No abstract available.
Similar articles
-
Enhanced Enrollment in the National Diabetes Prevention Program to Increase Engagement and Weight Loss for the Underserved: Protocol for a Randomized Controlled Trial.JMIR Res Protoc. 2020 Jun 1;9(6):e15499. doi: 10.2196/15499. JMIR Res Protoc. 2020. PMID: 32476659 Free PMC article.
-
Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes.Am J Health Promot. 2019 Feb;33(2):289-292. doi: 10.1177/0890117118786195. Epub 2018 Jul 9. Am J Health Promot. 2019. PMID: 29986597
-
Supplemental Text Message Support With the National Diabetes Prevention Program: Pragmatic Comparative Effectiveness Trial.JMIR Mhealth Uhealth. 2020 Jun 18;8(6):e15478. doi: 10.2196/15478. JMIR Mhealth Uhealth. 2020. PMID: 32554385 Free PMC article. Clinical Trial.
-
Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges.Diabetes Metab Syndr Obes. 2020 Aug 19;13:2949-2957. doi: 10.2147/DMSO.S218334. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32903871 Free PMC article. Review.
-
The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.Dan Med Bull. 1997 Jun;44(3):303-15. Dan Med Bull. 1997. PMID: 9233549 Review.
Cited by
-
Rethinking the Goals of Diabetes Prevention Programs.Diabetes Care. 2021 Nov;44(11):2457-2459. doi: 10.2337/dci21-0038. Diabetes Care. 2021. PMID: 34670795 Free PMC article. No abstract available.
-
Diabetes beliefs, perceived risk and health behaviours: an embedded mixed-methods analysis from the Richmond Stress and Sugar Study.BMJ Open. 2025 Feb 5;15(2):e089922. doi: 10.1136/bmjopen-2024-089922. BMJ Open. 2025. PMID: 39909528 Free PMC article.
-
A pre-conception clinical trial to reduce intergenerational obesity and diabetes risks: The NDPP-NextGen trial protocol.Contemp Clin Trials. 2023 Oct;133:107305. doi: 10.1016/j.cct.2023.107305. Epub 2023 Jul 27. Contemp Clin Trials. 2023. PMID: 37516162 Free PMC article.
-
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial.Diabetes Ther. 2024 May;15(5):1231-1244. doi: 10.1007/s13300-024-01560-3. Epub 2024 Mar 18. Diabetes Ther. 2024. PMID: 38494571 Free PMC article.
-
Glycemic Improvement and Health Equity in the National Diabetes Prevention Program.Diabetes Care. 2023 Jun 1;46(6):e128-e129. doi: 10.2337/dc23-0552. Diabetes Care. 2023. PMID: 37083982 Free PMC article. No abstract available.
References
-
- Centers for Disease Control and Prevention . National Diabetes Statistics Report, 2020: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA, U.S. Department of Health and Human Services, 2020
-
- American Diabetes Association . 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;44(Suppl. 1):S15–S33 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous